Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 413-110-2 | CAS number: 135861-56-2
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The substance will hydrolyse in stomach to sorbitol, which is mainly metabolised to carbon dioxide, and 3,4-dimethylbenzaldehyde which will be conjucated with glycine and excreted rapidly to urine.
Inhaled materials will behave like inert particulates, and are cleared from the lungs by the mucociliary system.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Orally administered test substance will hydrolyse in stomach to sorbitol and 3,4-dimethylbenzaldehyde. Sorbitol is slowly absorbed and mainly metabolised to carbon dioxide. 3,4-dimethylbenzaldehyde are expected to be oxidized to aromatic acid, which will be conjucated with glycine and excreted rapidly to urine.
Inhaled materials will behave like inert particulates, and are cleared from the lungs by the mucociliary system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
